Drugs / SHR-2001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05942612 | Jul 2023 → Nov 2024 | — | Guangdong Hengrui Pharmaceutical Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SHR-2001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05942612 ↗ |
| Route | Subcutaneous | “Subcutaneous injection, single dose or multiple doses.” NCT05942612 ↗ |